1. Home
  2. DCO vs NVCR Comparison

DCO vs NVCR Comparison

Compare DCO & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ducommun Incorporated

DCO

Ducommun Incorporated

HOLD

Current Price

$139.85

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$13.47

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCO
NVCR
Founded
1849
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.5B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
DCO
NVCR
Price
$139.85
$13.47
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
$148.60
$28.08
AVG Volume (30 Days)
154.8K
2.8M
Earning Date
05-29-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
$824,730,000.00
$655,353,000.00
Revenue This Year
$7.38
$7.72
Revenue Next Year
$8.58
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
4.85
8.28
52 Week Low
$51.76
$9.82
52 Week High
$135.82
$21.55

Technical Indicators

Market Signals
Indicator
DCO
NVCR
Relative Strength Index (RSI) 77.44 56.71
Support Level $87.68 $12.66
Resistance Level N/A $14.25
Average True Range (ATR) 5.55 1.19
MACD 0.75 0.30
Stochastic Oscillator 99.32 58.28

Price Performance

Historical Comparison
DCO
NVCR

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: